Literature DB >> 20676943

Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord.

Cun-Gang Fan1, Qing-jun Zhang, Jing-ru Zhou.   

Abstract

Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs), isolated from discarded extra-embryonic tissue after birth, are promising candidate source of mesenchymal stem cells (MSCs). Apart from their prominent advantages in abundant supply, painless collection, and faster self-renewal, hUC-MSCs have shown the potencies to differentiate into a variety of cells of three germ layers (such as bone, cartilage, adipose, skeletal muscle, cardiomyocyte, endothelium, hepatocyte-like cluster, islet-like cluster, neuron, astrocyte and oligodendrocyte), to synthesize and secret a set of trophic factors and cytokines, to support the expansion and function of other cells (like hematopoietic stem cells, embryonic stem cells, natural killer cells, islet-like cell clusters, neurons and glial cells), to migrate toward and home to pathological areas, and to be readily transfected with conventional methods. Two excellent previous reviews documenting the characteristics of this cell population with special emphasis on its niche, isolation, surface markers and primitive properties have been published recently. In this review, we will firstly give a brief introduction of this cell population, and subsequently dwell on the findings of differential capacities with emphasis on its therapeutic potentials.

Entities:  

Mesh:

Year:  2011        PMID: 20676943     DOI: 10.1007/s12015-010-9168-8

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  120 in total

1.  Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential.

Authors:  Pieternella S in 't Anker; Willy A Noort; Sicco A Scherjon; Carin Kleijburg-van der Keur; Alwine B Kruisselbrink; Rutger L van Bezooijen; Willem Beekhuizen; Roelof Willemze; Humphrey H H Kanhai; Willem E Fibbe
Journal:  Haematologica       Date:  2003-08       Impact factor: 9.941

2.  Comparison of fetal and adult marrow stromal cells in osteogenesis with and without glucocorticoids.

Authors:  Pi-Ling Chang; Harry C Blair; Xiaochu Zhao; Yi-wen Chien; Dungtsa Chen; Arabella B Tilden; Zhijie Chang; Xu Cao; Ona Marie Faye-Petersen; Patricia Hicks
Journal:  Connect Tissue Res       Date:  2006       Impact factor: 3.417

3.  Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.

Authors:  Hwai-Shi Wang; Shih-Chieh Hung; Shu-Tine Peng; Chun-Chieh Huang; Hung-Mu Wei; Yi-Jhih Guo; Yu-Show Fu; Mei-Chun Lai; Chin-Chang Chen
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

4.  Reproducible methodology for the isolation of mesenchymal stem cells from human umbilical cord and its potential for cardiomyocyte generation.

Authors:  Winston Costa Pereira; Italia Khushnooma; Manisha Madkaikar; K Ghosh
Journal:  J Tissue Eng Regen Med       Date:  2008-10       Impact factor: 3.963

5.  Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells.

Authors:  Rodrigo López-González; Philip Kunckles; Iván Velasco
Journal:  Cell Transplant       Date:  2009-08-05       Impact factor: 4.064

6.  Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease.

Authors:  Mark L Weiss; Satish Medicetty; Amber R Bledsoe; Raja Shekar Rachakatla; Michael Choi; Shosh Merchav; Yongquan Luo; Mahendra S Rao; Gopalrao Velagaleti; Deryl Troyer
Journal:  Stem Cells       Date:  2005-10-13       Impact factor: 6.277

7.  Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors.

Authors:  R S Rachakatla; F Marini; M L Weiss; M Tamura; D Troyer
Journal:  Cancer Gene Ther       Date:  2007-06-29       Impact factor: 5.987

8.  Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells.

Authors:  David Campard; Philippe A Lysy; Mustapha Najimi; Etienne Marc Sokal
Journal:  Gastroenterology       Date:  2007-12-23       Impact factor: 22.682

9.  5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.

Authors:  E Martin-Rendon; D Sweeney; F Lu; J Girdlestone; C Navarrete; S M Watt
Journal:  Vox Sang       Date:  2008-06-28       Impact factor: 2.144

10.  Human umbilical cord cells for cardiovascular tissue engineering: a comparative study.

Authors:  Alexander Kadner; Gregor Zund; Christine Maurus; Christian Breymann; Sidika Yakarisik; Gregor Kadner; Marko Turina; Simon P Hoerstrup
Journal:  Eur J Cardiothorac Surg       Date:  2004-04       Impact factor: 4.191

View more
  70 in total

1.  Bioceramic-mediated trophic factor secretion by mesenchymal stem cells enhances in vitro endothelial cell persistence and in vivo angiogenesis.

Authors:  Jiawei He; Martin L Decaris; J Kent Leach
Journal:  Tissue Eng Part A       Date:  2012-06-07       Impact factor: 3.845

Review 2.  Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells.

Authors:  Limin Wang; Lindsey Ott; Kiran Seshareddy; Mark L Weiss; Michael S Detamore
Journal:  Regen Med       Date:  2011-01       Impact factor: 3.806

3.  Quantitative Raman spectral changes of the differentiation of mesenchymal stem cells into islet-like cells by biochemical component analysis and multiple peak fitting.

Authors:  Xin Su; Shaoyin Fang; Daosen Zhang; Qinnan Zhang; Yingtian He; Xiaoxu Lu; Shengde Liu; Liyun Zhong
Journal:  J Biomed Opt       Date:  2015       Impact factor: 3.170

4.  Human Umbilical Cord Mesenchymal Stem Cells Overexpressing Nerve Growth Factor Ameliorate Diabetic Cystopathy in Rats.

Authors:  Wu WenBo; Zhang Fei; Du YiHeng; Wang Wei; Yan TingMang; Zhou WenHao; Liu QianRu; Liu HaiTao
Journal:  Neurochem Res       Date:  2017-09-26       Impact factor: 3.996

Review 5.  The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord.

Authors:  Ariff Bongso; Chui-Yee Fong
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

6.  Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming.

Authors:  Mehdi Najar; Gordana Raicevic; Hussein Fayyad-Kazan; Hussein Fayyad Kazan; Cécile De Bruyn; Dominique Bron; Michel Toungouz; Laurence Lagneaux
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

Review 7.  Therapeutic application of mesenchymal stem cells in bone and joint diseases.

Authors:  Yi Liu; Jianmei Wu; Youming Zhu; Jinxiang Han
Journal:  Clin Exp Med       Date:  2012-11-03       Impact factor: 3.984

8.  Human Wharton's jelly stem cell conditioned medium enhances freeze-thaw survival and expansion of cryopreserved CD34+ cells.

Authors:  Hao Daniel Lin; Ariff Bongso; Kalamegam Gauthaman; Arijit Biswas; Mahesh Choolani; Chui-Yee Fong
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

9.  Human Wharton's jelly stem cells, its conditioned medium and cell-free lysate inhibit the growth of human lymphoma cells.

Authors:  Hao Daniel Lin; Chui Yee Fong; Arijit Biswas; Mahesh Choolani; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

10.  Reversibly immortalized human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are responsive to BMP9-induced osteogenic and adipogenic differentiation.

Authors:  Yi Shu; Chao Yang; Xiaojuan Ji; Linghuan Zhang; Yang Bi; Ke Yang; Mengjia Gong; Xing Liu; Qi Guo; Yuxi Su; Xiangyang Qu; Guoxin Nan; Chen Zhao; Zongyue Zeng; Xinyi Yu; Ruyi Zhang; Shujuan Yan; Jiayan Lei; Ke Wu; Ying Wu; Liping An; Shifeng Huang; Cheng Gong; Chengfu Yuan; Wei Liu; Bo Huang; Yixiao Feng; Bo Zhang; Zhengyu Dai; Yi Shen; Wenping Luo; Xi Wang; Rex C Haydon; Hue H Luu; Russell R Reid; Jennifer Moriatis Wolf; Michael J Lee; Tong-Chuan He; Yasha Li
Journal:  J Cell Biochem       Date:  2018-08-04       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.